Eye­ing RNAi po­ten­tial in can­cer and fi­bro­sis, trans-Pa­cif­ic biotech Sir­naomics lines up $47M Se­ries C

With sup­port from a syn­di­cate that speaks to its ex­ten­sive Chi­na ties, Gaithers­burg, MD-based Sir­naomics has raised an ad­di­tion­al $22 mil­lion to close out its …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA